Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study
- 10 August 2026
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 49 (10) , 1812-1820
Abstract
OBJECTIVE: To determine whether weight loss during the initial years following diagnosis of impaired glucose tolerance (IGT) is independently associated with reduced long-term mortality and cardiovascular risk. RESEARCH DESIGN AND METHODS: In the Da Qing Diabetes Prevention Study, 540 adults with IGT were categorized into three groups based on their weight change from baseline to the end of a 6-year lifestyle intervention trial: non–weight loss (n = 200), low weight loss (<5%, n = 163), and high weight loss (≥5%, n = 177). Participants were followed for 34 years to assess all-cause mortality, cardiovascular disease (CVD) mortality, and CVD events. Cox models were used to assess associations. RESULTS: Weight loss during the initial 6 years following IGT diagnosis was associated with reduced long-term risks of CVD events and mortality (P = 0.007–0.015). Compared with participants without weight loss, those with weight loss ≥5% had significantly lower risks of CVD death (hazard ratio [HR] 0.56, 95% CI 0.35–0.89), CVD events (HR 0.71, 95% CI 0.52–0.99), hospitalized heart failure (HR 0.48, 95% CI 0.26–0.88), and all-cause death (HR 0.67, 95% CI 0.48–0.95) after adjusting for age, sex, baseline weight, and other covariates. Furthermore, the high weight loss group showed delays in the median time to all-cause mortality and CVD mortality of 2.1 years and 6.5 years, respectively. CONCLUSIONS: Weight loss achieved in the early years after diagnosis of IGT in Chinese adults is associated with substantially lower long-term risks of CVD events and mortality, suggesting the critical importance of early weight management in individuals with prediabetes for improving long-term survival and cardiovascular health.Keywords
All Related Versions
Funding Information
- High Level Hospital Clinical Research Funding (2024-GSP-GG-5)
- High Level Hospital Clinical Research Funding (2025 GSP-GG-6)
- Chronic Diseases National Science and Technology Major Project (2024ZD0531500)
- Chronic Diseases National Science and Technology Major Project (2024ZD0531505)
This publication has 36 references indexed in Scilit:
- Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)The Lancet, 2024
- Insulin resistance and incident heart failure: a meta‐analysisEuropean Journal of Heart Failure, 2022
- Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and OverCurrent Obesity Reports, 2017
- Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with ObesityCell Metabolism, 2016
- Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection FractionJAMA, 2016
- Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular ComplicationsJAMA, 2014
- Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up studyThe Lancet Diabetes & Endocrinology, 2014
- Obesity and Cardiovascular DiseaseJACC, 2009
- The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up studyThe Lancet, 2008
- Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention StudyThe Lancet, 2006